182 related articles for article (PubMed ID: 36081544)
1. Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis.
Yang WY; He Y; Hu Q; Peng M; Zhang Z; Xie S; Yu F
Front Oncol; 2022; 12():984932. PubMed ID: 36081544
[TBL] [Abstract][Full Text] [Related]
2. Thermal ablation versus radiotherapy for inoperable stage III non-small cell lung cancer: a propensity score matching analysis.
Yang WY; He Y; Peng M; Zhang Z; Xie S; Wu Z; Hu Q; Yu F
Int J Hyperthermia; 2023; 40(1):2154577. PubMed ID: 36535924
[TBL] [Abstract][Full Text] [Related]
3. Thermal Ablation Versus Wedge Resection for Stage I Non-small Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: A Population Study of the US SEER Database.
Zeng C; Lu J; Tian Y; Fu X
Front Oncol; 2020; 10():571684. PubMed ID: 33154946
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis.
Yang H; Li M; Mei T
Int J Hyperthermia; 2022; 39(1):348-357. PubMed ID: 35164638
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation
Li M; Xu X; Qin Y; Zhang P; Shen C; Xia Q; Fan L
J Cancer; 2021; 12(10):3057-3066. PubMed ID: 33854605
[No Abstract] [Full Text] [Related]
7. Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
Shang S; Wang R; Wang F; Wu M; Chen D; Yu J
Front Oncol; 2022; 12():874022. PubMed ID: 35785183
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
[TBL] [Abstract][Full Text] [Related]
9. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
10. Surgery versus radiotherapy in octogenarians with stage Ia non‑small cell lung cancer: propensity score matching analysis of the SEER database.
Ni L; Lin G; Zhang Z; Sun D; Liu Z; Liu X
BMC Pulm Med; 2022 Nov; 22(1):411. PubMed ID: 36357868
[TBL] [Abstract][Full Text] [Related]
11. Role of Pneumonectomy in T1-4N2M0 Non-Small Cell Lung Cancer: A Propensity Score Matching Analysis.
Wang S; Wang Q; Zhu W; Wei J; Feng D; Lv X; Liu M
Front Oncol; 2022; 12():880515. PubMed ID: 35795054
[TBL] [Abstract][Full Text] [Related]
12. Improved Survival With Surgical Treatment of Primary Lung Lesions in Non-Small Cell Lung Cancer With Brain Metastases: A Propensity-Matched Analysis of Surveillance, Epidemiology, and End Results Database.
Wang Q; Li J; Liang X; Zhan Q
Front Oncol; 2022; 12():888999. PubMed ID: 35936705
[TBL] [Abstract][Full Text] [Related]
13. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
14. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
Front Oncol; 2022; 12():938195. PubMed ID: 36119504
[TBL] [Abstract][Full Text] [Related]
15. Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?
Hao Z; Liang H; Zhang Y; Wei W; Lan Y; Qiu S; Lin G; Wang R; Liu Y; Chen Y; Huang J; Wang W; Cui F; Goto T; Jeong JY; Veronesi G; Lopez-Pastorini A; Igai H; Liang W; He J; Liu J
Transl Lung Cancer Res; 2021 Mar; 10(3):1408-1423. PubMed ID: 33889519
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Impact of Lymph Node Dissection on Primary Tumor Resection for Stage IV Non-Small Cell Lung Cancer: A Population-Based Study.
Zhang Y; Zhang Y; Cheng X; Dai K; Xu B; Liang S; Chen M; Zhang H; Chen Z
Front Oncol; 2022; 12():853257. PubMed ID: 35600401
[TBL] [Abstract][Full Text] [Related]
17. Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
Zou L; Guo T; Ye L; Zhou Y; Chu L; Chu X; Ni J; Zhu Z; Yang X
Front Oncol; 2020; 10():572462. PubMed ID: 33324549
[TBL] [Abstract][Full Text] [Related]
18. Survival value of primary tumour resection for stage IV non-small-cell lung cancer: A population-based study of 6466 patients.
Xu J; Fan L; Yu H; Lu D; Peng W; Sun G
Clin Respir J; 2020 Aug; 14(8):763-771. PubMed ID: 32301272
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database.
Zhang R; Li P; Li Q; Qiao Y; Xu T; Ruan P; Song Q; Fu Z
Cancer Med; 2018 Oct; 7(10):5015-5026. PubMed ID: 30239162
[TBL] [Abstract][Full Text] [Related]
20. Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database Study.
Uhlig J; Ludwig JM; Goldberg SB; Chiang A; Blasberg JD; Kim HS
Radiology; 2018 Dec; 289(3):862-870. PubMed ID: 30226453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
